Cargando…

Two well-differentiated pancreatic neuroendocrine tumor mouse models

Multiple endocrine neoplasia type 1 (MEN1) is a genetic syndrome in which patients develop neuroendocrine tumors (NETs), including pancreatic neuroendocrine tumors (PanNETs). The prolonged latency of tumor development in MEN1 patients suggests a likelihood that other mutations cooperate with Men1 to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Chung, Tang, Laura H., Davidson, Christian, Vosburgh, Evan, Chen, Wenjin, Foran, David J., Notterman, Daniel A., Levine, Arnold J., Xu, Eugenia Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206057/ https://www.ncbi.nlm.nih.gov/pubmed/31160716 http://dx.doi.org/10.1038/s41418-019-0355-0

Ejemplares similares

High-throughput Image Analysis of Tumor Spheroids: A User-friendly Software Application to Measure the Size of Spheroids Automatically and Accurately
por: Chen, Wenjin, et al.
Publicado: (2014)

Genetic analysis of the cooperative tumorigenic effects of targeted deletions of tumor suppressors Rb1, Trp53, Men1, and Pten in neuroendocrine tumors in mice
por: Xu, Eugenia Y., et al.
Publicado: (2020)

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
por: Wong, Chung, et al.
Publicado: (2012)

Sexual dimorphism of liver metastasis by murine pancreatic neuroendocrine tumors is affected by expression of complement C5
por: Contractor, Tanupriya, et al.
Publicado: (2016)

Alleles of Insm1 determine whether RIP1-Tag2 mice produce insulinomas or nonfunctioning pancreatic neuroendocrine tumors
por: Kobayashi, Shinta, et al.
Publicado: (2019)

Genomic characterization of a well-differentiated grade 3 pancreatic neuroendocrine tumor
por: Williamson, Laura M., et al.
Publicado: (2019)

Optimal Lymphadenectomy in Patients with Well-Differentiated Nonfunctioning Pancreatic Neuroendocrine Neoplasms
por: Shintakuya, Ryuta, et al.
Publicado: (2023)

The bromodomain and extra-terminal inhibitor CPI203 enhances the antiproliferative effects of rapamycin on human neuroendocrine tumors
por: Wong, C, et al.
Publicado: (2014)

Effect of Endostar combined with chemotherapy in advanced well-differentiated pancreatic neuroendocrine tumors
por: Cheng, Yue-Juan, et al.
Publicado: (2018)

Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors
por: Tan, Qing-quan, et al.
Publicado: (2020)

Updated Efficacy and Safety Outcomes for Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors Treated with Sunitinib
por: Fazio, Nicola, et al.
Publicado: (2021)

Primary Well-Differentiated Neuroendocrine Tumor of the Kidney
por: Prasad, Vishnu, et al.
Publicado: (2023)

Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor
por: Ito, Tetsuhide, et al.
Publicado: (2013)

Clinical and Molecular Risk Factors for Recurrence Following Radical Surgery of Well-Differentiated Pancreatic Neuroendocrine Tumors
por: Pulvirenti, Alessandra, et al.
Publicado: (2020)

Values of debulking surgery for unresectable well-differentiated metastatic pancreatic neuroendocrine tumors: a comparative study
por: Huang, Xi-Tai, et al.
Publicado: (2023)

Targeted deep sequencing reveals the genetic heterogeneity in well-differentiated pancreatic neuroendocrine tumors with liver metastasis
por: Zhou, Wentao, et al.
Publicado: (2022)

Well‑differentiated neuroendocrine tumor of the right kidney: A case report
por: Yang, Denghao, et al.
Publicado: (2023)

Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms
por: Hofland, Johannes, et al.
Publicado: (2020)

Transanal Endoscopic Microsurgery for the Treatment of Well-Differentiated Rectal Neuroendocrine Tumors
por: Kim, Hyoung Ran, et al.
Publicado: (2012)

hPG(80) (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors
por: Chauhan, Aman, et al.
Publicado: (2022)

Glyoxalase 1 copy number variation in patients with well differentiated gastro-entero-pancreatic neuroendocrine tumours (GEP-NET)
por: Xue, Mingzhan, et al.
Publicado: (2017)

An Advanced Well-differentiated Pancreatic Neuroendocrine Carcinoma (NET-G3) Associated with Von Hippel-Lindau Disease
por: Miki, Masami, et al.
Publicado: (2018)

Visceral Obesity Is Associated with Shorter Progression-Free Survival in Well-Differentiated Gastro-Entero-Pancreatic Neuroendocrine Neoplasia
por: Santos, Ana P., et al.
Publicado: (2022)

Metastatic well differentiated serotonin-producing pancreatic neuroendocrine tumor with carcinoid heart disease: a case report
por: Kudelka, Matthew R., et al.
Publicado: (2023)

Identification and Characterization of Poorly Differentiated Invasive Carcinomas in a Mouse Model of Pancreatic Neuroendocrine Tumorigenesis
por: Hunter, Karen E., et al.
Publicado: (2013)

Novel therapeutics for patients with well-differentiated gastroenteropancreatic neuroendocrine tumors
por: Das, Satya, et al.
Publicado: (2021)

Upregulation of Peroxiredoxin-2 in Well-Differentiated Pancreatic Neuroendocrine Tumors and Its Utility as a Biomarker for Predicting the Response to Everolimus
por: Kim, Eui Joo, et al.
Publicado: (2020)

Values of spleen-preserving distal pancreatectomy in well-differentiated non-functioning pancreatic neuroendocrine tumors: a comparative study
por: Huang, Xi-Tai, et al.
Publicado: (2022)

Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors
por: Kotteas, Elias A, et al.
Publicado: (2016)

Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor
por: Jiang, Hua, et al.
Publicado: (2022)

Gallbladder primary well-differentiated neuroendocrine tumor: A misdiagnosed case
por: Dammak, Nouha, et al.
Publicado: (2023)

Heart Failure in a Patient With Metastatic Well-Differentiated Neuroendocrine Tumor
por: Henderson, Amy, et al.
Publicado: (2023)

Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: a case report and review of the literature
por: Brizzi, Maria Pia, et al.
Publicado: (2015)

Involvement of Neutrophils in Metastatic Evolution of Pancreatic Neuroendocrine Tumors
por: Debien, Véronique, et al.
Publicado: (2021)

Clinicopathological characteristics and risk factors for recurrence of well-differentiated pancreatic neuroendocrine tumors after radical surgery: a case-control study
por: Zhang, Pan, et al.
Publicado: (2019)

Plasma protein biomarkers for the detection of pancreatic neuroendocrine tumors and differentiation from small intestinal neuroendocrine tumors
por: Thiis‐Evensen, Espen, et al.
Publicado: (2022)

Metastatic well-differentiated neuroendocrine carcinoma of the pancreas: case report and review of literature
por: Martin, Mersadies R, et al.
Publicado: (2009)

Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors
por: Li, Su-Chen, et al.
Publicado: (2013)

Well-differentiated neuroendocrine tumor of the stomach: A rare case at an uncommon site
por: Gumuscu, Burak, et al.
Publicado: (2016)

Visceral Obesity and Metabolic Syndrome Are Associated with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors
por: Santos, Ana P., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cg6eme26tl944l9mc3m9g6s2pf